TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 73 filers reported holding TANGO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $137,372 | +5.4% | 12,200 | -63.0% | 0.00% | – |
| Q2 2023 | $130,338 | 0.0% | 32,997 | 0.0% | 0.00% | – |
| Q1 2023 | $130,338 | +47.4% | 32,997 | +170.5% | 0.00% | – |
| Q4 2022 | $88,450 | -99.8% | 12,200 | 0.0% | 0.00% | – |
| Q3 2022 | $44,164,000 | -20.1% | 12,200 | 0.0% | 0.00% | – |
| Q2 2022 | $55,266,000 | -40.2% | 12,200 | 0.0% | 0.00% | – |
| Q1 2022 | $92,476,000 | -30.7% | 12,200 | 0.0% | 0.00% | – |
| Q4 2021 | $133,468,000 | – | 12,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,363,975 | $211,842,000 | 60.92% |
| Cormorant Asset Management, LP | 4,899,185 | $53,149,000 | 3.16% |
| Boxer Capital, LLC | 6,871,642 | $75,176,000 | 2.92% |
| Casdin Capital, LLC | 5,487,910 | $60,038,000 | 1.69% |
| Bain Capital Life Sciences Investors, LLC | 1,921,790 | $21,024,000 | 1.67% |
| Samsara BioCapital, LLC | 630,000 | $6,892,000 | 1.34% |
| TANG CAPITAL MANAGEMENT LLC | 468,750 | $5,128,000 | 1.03% |
| HARVARD MANAGEMENT CO INC | 708,385 | $7,750,000 | 0.73% |
| HHLR ADVISORS, LTD. | 3,873,982 | $42,381,000 | 0.66% |
| Southpoint Capital Advisors LP | 3,000,000 | $32,820,000 | 0.63% |